The Adherence and LDL-C Lowering Effect of Inclisiran Among Patients Who Received Treatment at Outpatient Clinics

被引：0
|
作者：
Desai, Nihar R.
Van Hise, Nicholas
Niu, Charlene
Ghera, Elizabeth
McElligott, Sean
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Atherosclerosis; Dyslipidemia; LDL; Cholesterol-lowering drugs; Cardiovascular disease;
D O I：
10.1161/circ.148.suppl_1.16180
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16180
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Variability of the LDL-C lowering response to ezetimibe and ezetimibe plus statin therapy in hypercholesterolemic patients
    Descamps, Olivier
    Tomassini, Joanne E.
    Lin, Jianxin
    Polis, Adam B.
    Shah, Arvind
    Brudi, Philippe
    Hanson, Mary E.
    Tershakovec, Andrew M.
    ATHEROSCLEROSIS, 2015, 240 (02) : 482 - 489
  • [32] MODELING THE POPULATION HEALTH BENEFITS OF LDL-C REDUCTION WITH ALIROCUMAB AMONG CARDIOVASCULAR DISEASE/HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS WITH ELEVATED LDL-C
    Sanchez, R.
    Nasir, K.
    Klimchak, A.
    Kuznik, A.
    Joulain, F.
    Briggs, A.
    ATHEROSCLEROSIS, 2018, 275 : E100 - E100
  • [33] Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US
    Marrett, Elizabeth
    Zhao, Changgeng
    Zhang, Ning Jackie
    Zhang, Qiaoyi
    Ramey, Dena R.
    Tomassini, Joanne E.
    Tershakovec, Andrew M.
    Neff, David R.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 237 - 246
  • [34] LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA
    Pan, Yuesong
    Wangqin, Runqi
    Li, Hao
    Jin, Aoming
    Li, Jiejie
    Lin, Jinxi
    Meng, Xia
    Xian, Ying
    Laskowitz, Daniel T.
    Wang, Yongjun
    STROKE AND VASCULAR NEUROLOGY, 2022, 7 (04) : 276 - 284
  • [35] LDL-C goal attainment and cardiovascular hospitalization among CHD patients in germany
    Raiagopalan, S
    Alemao, E
    Yin, D
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 119 - 119
  • [36] THE EFFECT OF AN INTENSIVE LIPID-LOWERING THERAPY PROTOCOL ON ACHIEVING TARGET LDL-C LEVELS IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Seiyama, Kosuke
    Oka, Akihiro
    Takagi, Wataru
    Okada, Tomoaki
    Nosaka, Kazumasa
    Miyoshi, Toru
    Doi, Masayuki
    ATHEROSCLEROSIS, 2024, 395
  • [37] Effects of a stepwise, structured LDL-C lowering strategy in patients post-acute coronary syndrome
    Aaram Omar Khader
    Tinka van Trier
    Sander van der Brug
    An-ho Liem
    Bjorn E. Groenemeijer
    Astrid Schut
    Harald T. Jorstad
    Fabrice M.A.C. Martens
    Marco A.M.W. Alings
    Netherlands Heart Journal, 2024, 32 : 206 - 212
  • [38] COST-EFFECTIVENESS OF LDL-C LOWERING WITH EVOLOCUMAB IN PATIENTS WITH HIGH CARDIOVASCULAR RISK IN THE UNITED STATES
    Gandra, S. R.
    Villa, G.
    Fonarow, G.
    Lothgren, M.
    Lindgren, P.
    Somaratne, R.
    van Hout, B.
    VALUE IN HEALTH, 2016, 19 (03) : A3 - A3
  • [39] Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
    Gandra, Shravanthi R.
    Villa, Guillermo
    Fonarow, Gregg C.
    Lothgren, Mickael
    Lindgren, Peter
    Somaratne, Ransi
    van Hout, Ben
    CLINICAL CARDIOLOGY, 2016, 39 (06) : 313 - 320
  • [40] Effects of a stepwise, structured LDL-C lowering strategy in patients post-acute coronary syndrome
    Omar Khader, Aaram
    van Trier, Tinka
    van der Brug, Sander
    Liem, An-ho
    Groenemeijer, Bjorn E.
    Schut, Astrid
    Jorstad, Harald T.
    Martens, Fabrice M. A. C.
    Alings, Marco A. M. W.
    NETHERLANDS HEART JOURNAL, 2024, 32 (05) : 206 - 212
12345